Key result
High-dose AAVMYO outperforms AAV8 and AAVMYO2, achieving ~20% transduction in muscle-resident mononuclear cells.
AAVMYO is superior to AAV8 and AAVMYO2 in transducing muscle-resident mononuclear cells in both healthy and dystrophic mouse models, providing a potential vector for gene therapy in muscular dystrophies.
Should not yet inform clinical gene therapy; leaves open AAVMYO for further preclinical optimization in muscular dystrophies.
Adeno-associated viruses (AAVs) of different serotypes are commonly used in gene therapies and gene interrogation studies to deliver transgenes to skeletal muscle in humans and mice. While efficient muscle fiber transduction is possible, little is known of their capacity to transduce muscle-residing mononuclear cells. Here, we addressed this question for AAV8 and the two myotropic AAVs, AAVMYO and AAVMYO2, by engineering them to express the tdTomato gene. AAVs were then injected intramuscularly or intravenously at two different doses into adult mice followed by flow-cytometry-based isolation of endothelial cells, immune cells, muscle stem cells, and fibro-adipogenic progenitor cells from the tibialis anterior muscle. Overall, we noted varying rates of tdTomato expression across all cell types. Transduction efficiency fluctuated in AAV serotype-dependent, titer-dependent, administration-dependent, and cell-dependent manners. By visualizing AAV DNA in vivo , we confirmed that AAV8, AAVMYO, and AAVMYO2 deliver transgenes to muscle-residing mononuclear cells. We show that mononuclear cells are also successfully transduced in the dy W / dy W mouse model of LAMA2-related muscular dystrophy. Altogether, we demonstrate that muscle-residing mononuclear cells are transduced by AAVs and provide an insightful guidance for researchers aiming to target muscle-resident mononuclear cells in their studies.
No takes yet. Share an insight, caveat, or question.
McGowan et al. (2025) studied Healthy and dystrophic skeletal muscle (animal model). AAVMYO and AAVMYO2 vs. AAV8 and PBS was evaluated on Proportion of tdTomato-expressing mononuclear cells (transduction efficiency). AAVMYO outperformed AAV8 and AAVMYO2 in transducing muscle-resident mononuclear cells at high doses, achieving over 20% transduction in muscle stem cells and fibro-adipogenic progenitors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: